Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340)
about
Redirecting SR Protein Nuclear Trafficking through an Allosteric Platform.Pharmacology of Modulators of Alternative Splicing.Therapeutic targeting of splicing in cancer.The role of RNA alternative splicing in regulating cancer metabolism.Enhancer of rudimentary homologue interacts with scaffold attachment factor B at the nuclear matrix to regulate SR protein phosphorylation.Therapeutic Applications of Targeted Alternative Splicing to Cancer Treatment.SRPKIN-1: A Covalent SRPK1/2 Inhibitor that Potently Converts VEGF from Pro-angiogenic to Anti-angiogenic Isoform.
P2860
Q38747768-A13A64E8-5294-4540-9F2A-4001D15747C3Q38776406-386EE7A8-0C70-4C50-9F48-AAB14D3079DDQ38948363-29BADA4E-E6CD-40B6-9D08-53F571A96402Q39253959-B68F5579-DAF6-4C65-A2E2-2159A9FCFF6EQ46348230-506C8C8B-C8DC-4189-9A7C-44FA03E08C03Q49519966-EEE13776-CC4D-4F87-809E-89F73218D7D8Q52686217-3ECD2CEF-AFF3-4B0D-BE9B-7394358CC190
P2860
Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340)
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Potential Antileukemia Effect ...... nyl)Isonicotinamide (SRPIN340)
@ast
Potential Antileukemia Effect ...... nyl)Isonicotinamide (SRPIN340)
@en
Potential Antileukemia Effect ...... nyl)Isonicotinamide (SRPIN340)
@nl
type
label
Potential Antileukemia Effect ...... nyl)Isonicotinamide (SRPIN340)
@ast
Potential Antileukemia Effect ...... nyl)Isonicotinamide (SRPIN340)
@en
Potential Antileukemia Effect ...... nyl)Isonicotinamide (SRPIN340)
@nl
prefLabel
Potential Antileukemia Effect ...... nyl)Isonicotinamide (SRPIN340)
@ast
Potential Antileukemia Effect ...... nyl)Isonicotinamide (SRPIN340)
@en
Potential Antileukemia Effect ...... nyl)Isonicotinamide (SRPIN340)
@nl
P2093
P2860
P50
P1433
P1476
Potential Antileukemia Effect ...... nyl)Isonicotinamide (SRPIN340)
@en
P2093
Abelardo Silva Júnior
Angelo Brunelli Albertoni Laranjeira
Eduardo Basílio de Oliveira
Germanna Lima Righetto
Gustavo Costa Bressan
Joana Gasperazzo Ferreira
Juliana Lopes Rangel Fietto
Leandro Licursi de Oliveira
Marcus Vinícius de Andrade Barros
Márcia Rogéria Almeida
P2860
P304
P356
10.1371/JOURNAL.PONE.0134882
P407
P50
P577
2015-08-05T00:00:00Z